India, June 3 -- Stem cells grown in space may help solve one of the biggest challenges in regenerative medicine: producing ...

The landmark success of a drug against an ‘undruggable’ cancer is spurring fresh optimism in the quest to treat seemingly ...

Researchers have identified that mutations to vgll3 that are beneficial in early life also reduce lifespan and contribute to ...

(NASDAQ: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (?d) T cell therapies and T cell engagers (TCEs) for cancer and autoimmune diseases, today announced the ...

Scientists have created the most detailed cell map to date showing how genetic variation influences inflammatory bowel disease (IBD), revealing the specific cells and genes that drive the disease.

In response to stress or damage, cells undergo senescence and stop dividing. However, if senescent cells accumulate in ...

Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, ...

Targeted therapies drive rising cancer survival rates, experts say Patients like Smithwick and Vacca exemplify living longer with cancer using new treatments Success hinges on cancers being tested for ...

They had ‘highly sensitized’ immune systems that usually reject donated organs, leaving them with few options for survival.

Early results reveal how a single‑cell spatial platform maps stromal barriers that limit antibody delivery and target engagement in human solid tumors.

Eben Rosenthal, MD, the Barry and Amy Baker Professor and Chair of the Department of Otolaryngology-Head and Neck Surgery at ...